CardioNerds
Cardionerds is an entertaining and educational medical cardiology podcast created by three cardiologists. They want to bring high yield cardiovascular concepts in a fun and engaging format for their listeners of all levels. Click below to learn more!
Advertisement
Dr. Amit Goyal details a study which explored the role of coronary sinus reducer in Coronary microvascular dysfunction.
The CardioNerds and expert faculty Dr. Mark Drazner assess a woman's heart failure status.
The possibility of DCBs to rescue side branches during provisional coronary bifurcation stenting is appealing.
The CardioNerds and Dr. Mark Drazner discuss the right heart failure device placement with an elderly patient.
The CardioNerds and expert faculty Dr. Biykem Bozkurt discuss a 63-year-old patient with hypertension and T2D.
Dr. Amit Goyal details the first-in-human study of the Magenta Elevate system.
The CardioNerds and colleagues review the differential diagnosis for peripartum cardiomyopathy.
A study shows how how advancements in diagnostic tools and treatments for ATTR-CM have improved risk profiles.
A recent post-hoc analysis of the ATTRibute-CM trial shows the potential for acoramidis in treating ATTR-CM.
The CardioNerds discuss a case involving a patient who presented with stress cardiomyopathy leading to cardiogenic shock.
A study highlights the significant HCRU and costs associated with ATTR-CM.
Promising long-term outcomes from the ongoing OLE of the ATTRibute-CM trial highlight the efficacy of acoramidis.
The CardioNerds and Dr. Mark Drazner discuss the correct heart failure status for a 50-year-old woman with a history of CHF.
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
ECLIPSE investigated whether OA provides better outcomes than conventional balloon angioplasty in calcified coronary lesions.
An analysis of PROTECTED TAVR trial highlighted potential regional differences in the efficacy of CEP during TAVR.
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
The MATTERHORN trial demonstrates that, for patients with HF and FMR, M-TEER is non-inferior to surgical mitral valve repair.
The RESHAPE-HF2 trial offers further insights into the transcatheter management of patients with HFrEF and FMR.
The CardioNerds and colleagues from MedStar Health discuss an usual case of cobalt cardiomyopathy.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.